Lobotomy as an effective psychiatric treatment

Severing or destroying connections in the frontal lobes was treated as therapeutically beneficial enough to justify lobotomy as a routine or institutional treatment for schizophrenia and other severe psychiatric or behavioral conditions.

3 episodes

Current understanding

The broad prefrontal and transorbital lobotomies of the mid-twentieth century were not supported by evidence strong enough to justify their widespread, irreversible use. Early claims relied heavily on uncontrolled case series and on outcomes such as reduced agitation or easier institutional management, while results were inconsistent and serious harms included personality and cognitive changes, apathy or disinhibition, seizures, neurological injury, and death. Some patients were reported to improve, but improvement did not establish that large destructive frontal lesions were a specific or proportionate treatment. Modern psychiatric neurosurgery uses much more targeted techniques for rare, highly selected refractory conditions and should not be conflated with historical lobotomy.

Consequences and human impact

Lobotomy moved from an experimental operation into government hospitals and national psychiatric systems despite uncertain efficacy and irreversible neurological harm. The institutional endorsement reached from state mental hospitals and the U.S. Veterans Administration to the 1949 Nobel Prize for the claimed therapeutic value of leucotomy. In several systems the procedure was used partly because it made severely disturbed institutional patients easier to manage.

How the consequences followed

The historical error concerns the broad destructive lobotomy procedures of the 1930s–1970s. Modern stereotactic and neuromodulatory psychiatric neurosurgery uses different techniques, indications and evidence and is not scientifically equivalent to historical lobotomy.

Reports that some lobotomized patients improved do not establish broad efficacy. Institutions often counted reduced agitation, reduced aggression, discharge, or easier ward management as therapeutic success. Those outcomes must be weighed against irreversible changes in cognition, motivation and personality and against the weak controls in much of the original evidence.

1949

Nobel Prize awarded for the claimed therapeutic value of leucotomy in certain psychoses

47 VA hospitals

authorized to conduct lobotomy programs in the United States by June 1950

≈4,500

people lobotomized in Sweden during its mid-century psychosurgery era

Quantitative figures are highlighted only when the cited evidence supports them. The scale of a related catastrophe is not automatically treated as a death toll caused solely by this belief.

Institutional episode

Norway

1941–1974Policy basis

Norway used lobotomy in psychiatric hospitals from 1941 until 1974. Later government reviews concluded that the intervention had been regarded by the profession as acceptable at the time, even though it produced irreversible outcomes, personality changes, epilepsy and deaths and could be performed without the consent standards expected today. After a national inquiry, the government created a general compensation scheme for people who had undergone the procedure.

Institutions

Norwegian psychiatric hospitals
Gaustad Hospital
Norwegian health authorities

Documented consequences

Irreversible psychosurgery performed on psychiatric patients without a modern consent standard
Personality changes and cognitive or functional impairment
Elevated risk of epilepsy and other neurological sequelae
Deaths associated with the operation
Later nationwide state compensation for surviving people who had undergone lobotomy

Institutional machinery

Norwegian psychiatric hospitals began lobotomy at Gaustad in 1941 and the procedure spread to most hospitals over the following years. Government retrospectives describe a system in which the practice continued into the 1970s. Historical compensation records also make the autonomy and consent framework unusually clear: explicit consent from the patient, guardian, or relatives was not necessarily required under the rules then used. In the 1990s Norway investigated the practice nationally and established a general compensation scheme covering everyone documented as having been lobotomized from 1941 through 1974.

Sources and what they establish

NOU 2011:9 — Økt selvbestemmelse og rettssikkerhetNorwegian Government
Official government historical review stating that lobotomy began at Gaustad in 1941, spread to most hospitals, declined after antipsychotic medication was introduced, and ceased in the 1970s.
St.meld. nr. 44 (2003–2004) — compensation schemes, section on lobotomized patientsNorwegian Government
Official account of the national lobotomy inquiry and compensation scheme. It emphasizes the irreversibility of the operation, general personality changes, epilepsy and other sequelae, deaths, and compensation for everyone documented as lobotomized during 1941–1974.
St.prp. nr. 29 (1996–97) — compensation cases for people subjected to lobotomyNorwegian Government
Official compensation record reproducing the historical evaluation criteria and stating that patient consent or explicit consent from a guardian or relatives was not required under the contemporary framework; it also documents disputed indications, young patients and later sequelae.

Institutional episode

Sweden

1944–1964Policy basis

Sweden adopted lobotomy rapidly after its introduction in 1944, including large programs at the state mental hospitals Umedalen and Sidsjön. Approximately 4,500 people were ultimately lobotomized, most commonly for schizophrenia, and the state health authority largely left implementation to individual hospital superintendents even where mortality was high. Umedalen alone performed 771 operations with 7.4% postoperative mortality. Use declined during the 1950s but continued into the early 1960s.

Institutions

Swedish National Board of Health (Medicinalstyrelsen)
Umedalen State Mental Hospital
Sidsjön State Mental Hospital
Swedish state mental-hospital system

Documented consequences

Thousands of people underwent irreversible psychosurgery in psychiatric institutions
Women were disproportionately represented among operated patients
Some state hospitals experienced substantial postoperative mortality
General surgeons performed lobotomies at institutions without specialist neurosurgical facilities
Personality alteration and behavioral quieting could be counted as treatment success

Institutional machinery

Swedish neurosurgeons and psychiatrists began prefrontal lobotomy in 1944. Umedalen and Sidsjön state mental hospitals adopted it on a large scale in 1946–1947, and the practice spread nationally with medical superintendents given broad autonomy by the state mental-health administration. Historical research estimates roughly 4,500 Swedish lobotomies, with women forming a majority and schizophrenia the dominant diagnosis. At Umedalen, 771 lobotomies were performed from 1947–1958 with 7.4% postoperative mortality. The international professional endorsement was reinforced in 1949 when the Nobel Prize in Physiology or Medicine was awarded to Egas Moniz for the claimed therapeutic value of leucotomy.

Sources and what they establish

Psychosurgery in Sweden 1944–1958: the practice, the professional and media discourseUmeå University / SwePub, National Library of Sweden
Doctoral research documenting rapid state-hospital implementation, approximately 4,500 Swedish lobotomies, 771 operations and 7.4% mortality at Umedalen, the predominance of women and schizophrenia, and the limited restraining role of the Swedish National Board of Health.
Lobotomi — Motion 2006/07:So394Sveriges riksdag
Parliamentary record summarizing the Swedish historical evidence: around 4,500 people lobotomized, 61% women, schizophrenia as the most common diagnosis, high mortality, and regular lobotomy continuing as late as 1963.
The Nobel Prize in Physiology or Medicine 1949Nobel Prize Outreach
Official Nobel record showing that Egas Moniz received half of the 1949 medicine prize for the 'therapeutic value of leucotomy in certain psychoses,' an unusually prominent institutional endorsement during the procedure's expansion.

Institutional episode

United States — Veterans Administration

1944–1960Policy basis

The U.S. Veterans Administration adopted prefrontal lobotomy as a treatment for severe psychiatric illness during and after World War II. By 1950 it had authorized programs at 47 hospitals and treated more than 1,400 veterans, while describing the operation as appropriate for selected patients. Yet the VA's own researchers had already found that supposed benefits were not clearly reflected in discharge or independent functioning, prompting a six-hospital comparative study. Lobotomy remained in the VA treatment and research system through the 1950s before the mass program gave way to psychopharmacology and tighter controls.

Institutions

United States Veterans Administration
Veterans Administration neuropsychiatric hospitals

Documented consequences

Irreversible brain surgery on hospitalized veterans with psychiatric disorders
Large-scale institutional exposure across dozens of federal hospitals
Personality and behavioral changes treated partly as therapeutic success
Risk of seizures, neurological injury, dependency and death
Continued clinical use while the federal system was still trying to determine which patients, if any, benefited

Institutional machinery

The Veterans Administration institutionalized frontal lobotomy in its postwar psychiatric system. Its 1944 annual report recorded special physician training and introduction of prefrontal lobotomy at several hospitals. By June 1950, 47 VA hospitals were authorized to operate lobotomy programs and more than 1,400 VA psychiatric patients had undergone the operation, most of them people diagnosed with chronic schizophrenia. The VA described lobotomy as an established appropriate treatment in selected cases while simultaneously launching a cooperative study because the evidence remained uncertain. The multi-hospital research program continued through the 1950s as psychotropic drugs began displacing lobotomy; the 1960 endpoint marks the end of the mass-program era rather than a single national ban.

Sources and what they establish

Annual Report of the Administrator of Veterans Affairs for Fiscal Year 1950United States Veterans Administration
Primary federal annual report stating that 47 hospitals were authorized to conduct lobotomy programs, more than 1,400 VA patients had been operated on by 30 June 1950, and lobotomy had established itself as an appropriate treatment in selected psychiatric cases while a controlled multi-hospital evaluation was being organized.
The Veterans Administration study of prefrontal lobotomyJournal of Clinical and Experimental Psychopathology / PubMed
Primary 1959 publication of the Veterans Administration cooperative study, documenting the federal system's formal evaluation of prefrontal lobotomy in veterans.
Psychosurgery, ethics, and media: a history of Walter Freeman and the lobotomyNeurosurgical Focus / PubMed
Peer-reviewed historical review of the U.S. lobotomy movement, its widespread clinical adoption, poor outcomes, ethical problems, and decline with regulatory scrutiny and antipsychotic medication.

Last reviewed: 24/08/2026